Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Depreciation and Depletion: 2018-2025

Historic Depreciation and Depletion for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to $4.0 million.

  • Organogenesis Holdings' Depreciation and Depletion rose 12.86% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 14.10%. This contributed to the annual value of $13.6 million for FY2024, which is 30.39% up from last year.
  • Organogenesis Holdings' Depreciation and Depletion amounted to $4.0 million in Q3 2025, which was up 7.90% from $3.7 million recorded in Q2 2025.
  • Organogenesis Holdings' Depreciation and Depletion's 5-year high stood at $4.0 million during Q3 2025, with a 5-year trough of $1.0 million in Q1 2021.
  • In the last 3 years, Organogenesis Holdings' Depreciation and Depletion had a median value of $3.4 million in 2024 and averaged $3.2 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first decreased by 24.83% in 2022, then spiked by 100.00% in 2023.
  • Over the past 5 years, Organogenesis Holdings' Depreciation and Depletion (Quarterly) stood at $1.8 million in 2021, then fell by 14.51% to $1.5 million in 2022, then skyrocketed by 96.96% to $3.0 million in 2023, then rose by 21.23% to $3.6 million in 2024, then climbed by 12.86% to $4.0 million in 2025.
  • Its Depreciation and Depletion was $4.0 million in Q3 2025, compared to $3.7 million in Q2 2025 and $3.4 million in Q1 2025.